Table 4.
At least possibly related to treatment grade ≥ 2 adverse events experienced by at least 3 patients
| Adverse Event * | Patients (N=29) | |||
|---|---|---|---|---|
| Grade 2 n (%) |
Grade 3 n (%) |
Grade 4 n (%) |
Overall n (%) |
|
| Anemia | 9 (31) | 3 (10.3) | 0 | 12 (41.4) |
| Fatigue | 10 (34.5) | 0 | 0 | 10 (34.5) |
| Anorexia | 9 (31) | 0 | 0 | 9 (31) |
| Hypoalbuminemia | 6 (20.7) | 2 (6.9) | 0 | 8 (27.6) |
| Hypophosphatemia | 2 (6.9) | 5 (17.2) | 0 | 7 (24.1) |
| Nausea | 6 (20.7) | 1 (3.4) | 0 | 7 (24.1) |
| Mucositis | 5 (17.2) | 1 (3.4) | 0 | 6 (20.7) |
| Vomiting | 3 (10.3) | 2 (6.9) | 0 | 5 (17.2) |
| Diarrhea | 4 (13.8) | 1 (3.4) | 0 | 5 (17.2) |
| Hypokalemia | 4 (13.8) | 1 (3.4) | 0 | 5 (17.2) |
| Hypertension | 2 (6.9) | 3 (10.3) | 0 | 5 (17.2) |
| Dyspnea | 2 (6.9) | 2 (6.9) | 0 | 4 (13.8) |
| Leukopenia | 2 (6.9) | 1 (3.4) | 1 (3.4) | 4 (13.8) |
| Abdominal pain | 1 (3.4) | 2 (6.9) | 0 | 3 (10.2) |
| Dehydration | 2 (6.9) | 1 (3.4) | 0 | 3 (10.2) |
| Hyperglycemia | 2 (6.9) | 1 (3.4) | 0 | 3 (10.2) |
| Hyponatremia | 0 | 3 (10.3) | 0 | 3 (10.2) |
| Neutropenia | 1 (3.4) | 0 | 2 (6.9) | 3 (10.2) |
| Thrombocytopenia | 3 (10.3) | 0 | 0 | 3 (10.2) |
*
No Grade 5 Adverse Events were noted